News

iSTAR Medical’s “emerging technology” presented at IGC

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, has been presented as part of the ‘Emerging Technologies’ session at the prestigious 2020 virtual Interventional Glaucoma Congress (IGC) meeting. Dr Paul Singh, who presented iSTAR Medical’s technology, is a glaucoma specialist, President of The Eye Centers of Racine & Kenosha (Wisconsin, USA) and one of […]

BVA Venture Company of the Year

iSTAR Medical wins BVA Award 2020!

iSTAR Medical has been awarded the 2020 BVA Venture Company of the Year at the BVA Award virtual ceremony today. The BVA Award is organised by the Belgian Venture Capital & Private Equity Association to reward and celebrate high-performing Belgian companies backed by private equity or venture capital funds. “We are honoured and excited by […]

iSTAR Medical’s CEO at OIS Glaucoma Innovation Showcase

CEO Michel Vanbrabant will illustrate the latest results for iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIject at the Glaucoma Innovation Showcase today. iSTAR Medical was selected as one of eight companies to showcase innovative glaucoma treatments to prospect investors at today’s meeting organised by the Ophthalmology Innovation Summit (OIS). iSTAR Medical recently announced consistently […]

Meet iSTAR Medical’s new logo

Let us introduce you to iSTAR Medical’s new logo. Our ‘eye’ embeds our purpose: improving the vision and lives of patients with glaucoma through powerful and safe ophthalmic implants with bio-integration. The foundation of our technology is the proprietary, microporous, anti-fibrotic STAR® material, combined with intuitive access into the supraciliary space. The unique outcomes: powerful enhancement of […]

MINIject’s STAR-I and II trial data to be presented at ESCRS

Positive results from two clinical trials of iSTAR Medical’s micro-invasive glaucoma surgery (MIGS) implant MINIjectTM  will be presented at the European Society of Cataract and Refractive Surgery (ESCRS) meeting on October 2-4.